Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 24, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - October 24, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 30     Next >>     Go To Page:

10/24/14 - BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In the U.S., the FDA has accepted for priority review the Biologics License Application for previously treated advanced melanoma and the Prescription Drug User Fee Act goal date for a decision is March 30, 2015. The FDA also granted Opdivo Breakthrough Therapy Designation for this indication. During the third quarter of 2014, the Company and Pfizer
10/24/14 - Research and Markets Offers Report: 'North America Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And... [Professional Services Close - Up]
Research and Markets Offers Report:' North America Pharmaceutical Packaging Market- By Primary Packaging Material, Type Of Packaging, Geography And Vendors- Forecasts, Trends And Shares'. Research and Markets reported the addition of the "North America Pharmaceutical Packaging Market- By Primary Packaging Material, Type Of Packaging, Geography And
10/23/14 - Reflexonic LLC Cleared for OTC Sales of Viberect ED Treatment in the US
Reflexonic LLC, developer of the Viberect non-pharmaceutical device for treating erectile dysfunction in men, has achieved Food and Drug Administration clearance to market the product over the counter in the US. Viberect is already registered for sale so far in the US, European Union, Australia, Canada and India. Now, with support from Austin, Tex.
10/22/14 - Middle East And Africa Pharmaceutical Packaging Market -By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)
Middle East and Africa regions have been a small percentage of the global pharmaceutical sales but it is changing with big companies are going to open production facilities in this region. In the Middle East with the economy growth to more than 5% in 2012 and the population also growing, there is a growing demand for medicines. In 2011, the Afric
10/22/14 - Veterinarian Cautions Against Using Unnecessary Over-the-Counter Drugs
Kansas State University issued the following news release:. If your small dog or cat has discoloration around the eye, be cautious when using over-the-counter medication to clear it up, according to a Kansas State University veterinarian. Jessica Meekins, ophthalmologist at the Veterinary Health Center at Kansas State University's College of Veteri
10/21/14 - AnthroTronix Secures FDA Clearance for Brain Health Assessment Tool [Health & Beauty Close - Up]
"We are pleased that DANA has sought and received FDA clearance, leading the way for this type of game-changing technology," said Corinna Lathan, founder and CEO of AnthroTronix. "With the steady growth of the mHealth movement, technology that has evidence and science-based functionality is critical," said Duke University Medical Center's Murali D
10/21/14 - Asia Pacific Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)
This region is home to more than half of the human beings in the world. The region has a steady economic growth. The GDP growth for 2014-2015 is forecasted to be more than 5% which is helped by growth in economies, robust credit growth and good labour markets. This growth has been seen by the global pharmaceutical companies who are investing heav
10/21/14 - Generic Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld
Even as demand surged for the industry's products, revenue for the Generic Pharmaceutical Manufacturing industry in Canada has stumbled over the past five years. Market share concentration in the Generic Pharmaceutical Manufacturing industry in Canada is very high, with the four largest industry players generating a large majority of total industry
10/21/14 - NAFDAC, counterfeiting and public health [Sun, The (Nigeria)]
Sometime in 2005, a friend took ill at workplace in one of the federal parastatals in Lagos and had to visit the Staff Clinic. An experienced doctor after thoroughly examining him put his finger on the cause of his sickness by correctly diagnosing malaria. The doctor prescribed an anti-malaria drug, Halfan, for treatment and because the medicine wa
10/21/14 - New Market Report: United States Pharmaceuticals & Healthcare Report Q4 2014
New Healthcare market report from Business Monitor International: "United States Pharmaceuticals& Healthcare Report Q4 2014" Boston, MA 10/21/2014 The US pharmaceutical market presents strong commercial opportunities across the industry. The Centers for Medicare and Medicaid Services has announced a 1.4% rate update for 3,400 acute care hospi
10/21/14 - Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker
Bloomberg, citing unnamed sources, said Omega could be worth up to $5.1 billion, with final offers expected next month. Also bidding are Perrigo Co. plc and privately held Boehringer Ingelheim, according to Bloomberg. Privately held Omega had $166 million in revenue for the first six months of 2014, up 60 percent from a year earlier, Bloomberg said
10/21/14 - Study finds drugs still in recalled supplements
Pieter Cohen, an internist and researcher at Cambridge Health Alliance, a Boston- area health care system. The tested supplements were recalled by manufacturers after FDA raised concerns about drugs in their products. "There should be significant legal and financial consequences for manufacturers who the FDA finds to be continuing to sell these sp
10/21/14 - U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014/ PRNewswire/ The U.S. Food and Drug Administration has accepted the filing of a New Drug Application for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults with type 2 diabetes. Empagliflozin pl
10/20/14 - GNW-News: Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis (english)
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 for patients with moderate-to-severe plaque psoriasis. Novartis International AG/ Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 for patients with moderate-to-severe plaque psoriasis. 17 A inhibitor, is currently under FDA...
10/20/14 - NAFDAC, Counterfeiting and Public Health [opinion]
SOMETIME in 2005, a friend took ill at workplace in one of the federal parastatals in Lagos and had to visit the staff clinic. An experienced doctor after thoroughly examining him put his finger on the cause of his sickness by correctly diagnosing malaria. The doctor prescribed an anti-malaria drug for treatment and because the medicine was out of
10/20/14 - North America Pharmaceutical Packaging Market Outlook 2019 - Major Vendors for the $26 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam...
North America Pharmaceutical Packaging Market Outlook 2019- Major Vendors for the $26 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. By a News Reporter-Staff News Editor at Pharma Business Week Research and Markets has announced the addition of the "North America Pharmaceutical Packaging Market- By Primary Packagin
10/20/14 - Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis
There is a need for novel therapies as not all treatments are appropriate or effective in every patient, "said Vas Narasimhan, Global Head Development, Novartis Pharmaceuticals. We look forward to working with the FDA as it finalizes its review. " In these studies, secukinumab met all primary and key secondary endpoints, including Psoriasis Area an
10/20/14 - Pinney Associates, Inc. Celebrates 20th Anniversary
Pinney Associates, Inc. celebrates 20 years of helping consumer healthcare and pharmaceutical companies to make science-based decisions for the betterment of public health. Founded in 1994 by John Pinney, today Pinney Associates is a consulting leader in prescription to over-the-counter switch, the support of marketed consumer healthcare products
10/20/14 - Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration granted Fast Track designation for TAS-102, an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer, and that the Company has initiated a rolling NDA submission to
10/20/14 - Takeda and Orexigen Announce Availability of CONTRAVE (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults
DEERFIELD, Ill. and OSAKA, Japan, Oct. 20, 2014/ PRNewswire/ Takeda Pharmaceutical Company Limited, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen Therapeutics, Inc. jointly announced today that Contrave extended-release tablets are now available to patients by prescription in pharmacies across the United State
10/20/14 - WALGREEN CO - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
Factors that might cause a difference include, but are not limited to, those discussed under "Cautionary Note Regarding Forward-Looking Statements" below and in Item 1 A of this Form 10- K. References herein to " Walgreens," the "Company," "we," "us" or "our" refer to Walgreen Co. and its subsidiaries included in the consolidated financial statemen
10/19/14 - AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool [EMBIN (Emerging Markets Business Information News]
? ?We are pleased that DANA has sought and received FDA clearance, leading the way for this type of game-changing technology, ? said Corinna Lathan, founder and CEO of AnthroTronix. ? ?In essence, measuring reaction time is like taking the temperature of the brain? like a' Brain Thermometer'? and it is a vital par
10/19/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma [EMBIN (Emerging Markets Business Information News]
Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimize TV media campaigns. ? ?AdVantics Rx is a game changer for th
10/19/14 - OTC Daily Alert Stock Watch - Acura Pharmaceuticals, Inc., (NASDAQ: ACUR)
Today's alerts include: Acura Pharmaceuticals, Inc.,; FRIDAY CLOSE$. 58. Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Acura Pharmaceuticals, Inc. was founded in 1935 and is based in
10/19/14 - OTC Daily Alert Stock Watch - Adamas Pharmaceuticals, Inc., (NASDAQ: ADMS)
Today's alerts include: Adamas Pharmaceuticals, Inc.,; FRIDAY CLOSE $14.54. Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. Adamas Pharmaceuticals, Inc. was founded in 2000 and is...
Articles(s): 1 - 25 of 30     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415